Suboptimal hemoglobin levels: do they impact patients and their therapy? Audience responses. [electronic resource]
Producer: 20000620Description: 18-9 p. digitalISSN:- 0093-7754
- Aged
- Anemia -- chemically induced
- Antineoplastic Agents -- adverse effects
- Blood Transfusion
- Epoetin Alfa
- Erythropoietin -- therapeutic use
- Europe
- Evidence-Based Medicine
- Female
- Hematinics -- therapeutic use
- Hemoglobins -- drug effects
- Humans
- Male
- Middle Aged
- Neoplasms -- complications
- Practice Patterns, Physicians'
- Quality of Life
- Recombinant Proteins
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.